Angiodynamics Income Statement (2010-2026) | ANGO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Aug2021	Nov2021	Feb2022	May2022	Aug2022	Nov2022	Feb2023	May2023	Aug2023	Nov2023	Feb2024	May2024	Aug2024	Nov2024	Feb2025	May2025	Aug2025	Nov2025	Feb2026	May2026
Revenue & cost
Revenue (Quarter)	76.97M	78.28M	73.97M	87.00M	81.54M	85.43M	80.71M	91.07M	78.68M	79.07M	75.18M	70.98M	67.49M	72.84M	72.00M	80.16M	75.71M	79.43M	78.42M	86.61M
Cost of Revenue (Quarter)	36.83M	37.73M	35.39M	40.54M	39.23M	40.35M	40.21M	44.72M	38.62M	38.81M	39.32M	32.47M	30.77M	32.94M	33.15M	37.94M	33.85M	34.65M	36.94M	39.83M
Gross Profit (Quarter)	40.14M	40.55M	38.58M	46.45M	42.30M	45.08M	40.50M	46.36M	40.06M	40.26M	35.86M	38.52M	36.72M	39.91M	38.86M	42.22M	41.86M	44.78M	41.48M	46.77M
Operating items
Amortization - Intangibles (Quarter)	4.82M	4.90M	4.90M	4.85M	4.84M	4.80M	4.74M	4.41M	3.60M	3.60M	3.29M	2.55M	2.60M	2.60M	2.60M	2.60M	2.65M	2.64M	2.70M	2.68M
Research & Development (Quarter)	24.45M	8.20M	20.42M	72.43M	26.54M	6.84M	25.41M	7.86M	7.94M	8.66M	25.41M	-10.49M	6.29M	25.59M	25.50M	6.59M	6.42M	26.71M	7.08M	92.13M
Selling, General & Administrative (Quarter)	8.94M	9.68M	8.73M	11.10M	10.10M	10.84M	8.84M	10.23M	10.86M	9.29M	10.58M	10.44M	10.97M	10.39M	10.49M	10.24M	12.55M	10.15M	10.72M	10.27M
Restructuring Costs (Quarter)	2.44M	2.25M	2.36M	1.99M	5.58M	3.06M	3.37M	3.62M	3.21M	6.19M	35.37M	8.41M	4.31M	5.87M	3.29M	2.15M	2.76M	3.63M	19.30M	4.68M
Other Operating Expenses (Quarter)	12.41M	29.10M	12.38M	-32.67M					47.84M		6.66M						30.78M	10.41M	17.33M	-50.11M
Operating Expenses (Quarter)	48.24M	49.23M	43.88M	52.85M	55.61M	53.19M	49.43M	67.20M	52.87M	53.38M	242.41M	52.96M	49.82M	51.00M	48.83M	48.01M	52.51M	50.91M	54.43M	56.97M
Operating Income (Quarter)	-8.10M	-8.68M	-5.29M	-6.40M	-13.30M	-8.12M	-8.93M	-20.84M	35.03M	-13.12M	-199.90M	-14.45M	-13.10M	-11.09M	-9.97M	-5.79M	-10.66M	-6.12M	-12.95M	-10.20M
EBIT (Quarter)	-8.10M	-8.68M	-5.29M	-6.40M	-13.30M	-8.12M	-8.93M	-20.84M	35.03M	-13.12M	-199.90M	-14.45M	-13.10M	-11.09M	-9.97M	-5.79M	-10.66M	-6.12M	-12.95M	-10.20M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	-0.35M	-0.01M	-0.29M	-0.14M	-0.17M	-0.25M		-0.13M	-0.29M	-0.03M	-0.24M	-0.26M	-0.17M	0.01M	5.43M	-0.33M	-0.18M	-0.13M	4.97M	-0.73M
Non Operating Income (Quarter)	-0.51M	-0.18M	-0.46M	-0.32M	-0.56M	-0.94M	-0.74M	-0.47M	-0.17M	0.53M	0.16M	1.12M	0.43M	0.25M	5.57M	-5.27M	-0.00M	-0.23M	4.88M	-4.77M
Net income details
EBT (Quarter)	-8.61M	-8.86M	-5.76M	-6.72M	-13.86M	-9.05M	-9.66M	-21.86M	34.86M	-12.62M	-199.74M	-14.14M	-12.66M	-10.85M	-4.41M	-6.11M	-10.84M	-6.36M	-8.07M	-11.04M
Tax Provisions (Quarter)	-1.64M	-0.51M	-0.80M	-0.46M	-0.85M	-0.56M	-0.18M	-0.40M	-11.02M	16.43M	-12.00M	-0.69M	0.13M	-0.11M	-0.00M	-0.06M	0.07M	-0.01M	0.01M	0.37M
Profit After Tax (Quarter)	-6.97M	-8.35M	-4.96M	-13.00M	-13.00M	-8.49M	-9.48M	-21.47M	45.88M	-29.05M	-187.74M	-13.45M	-12.80M	-10.74M	-4.41M	-6.05M	-10.90M	-6.35M	-8.08M	-11.40M
Income from Continuing Operations (Quarter)	-6.97M	-8.35M	-4.96M	-6.27M	-13.00M	-8.49M	-9.48M	-21.47M	45.88M	-29.05M	-187.74M	-13.45M	-12.80M	-10.74M	-4.41M	-6.05M	-10.90M	-6.35M	-8.08M	-11.40M
Consolidated Net Income (Quarter)	-6.97M	-8.35M	-4.96M	-6.27M	-13.00M	-8.49M	-9.48M	-21.47M	45.88M	-29.05M	-187.74M	-13.45M	-12.80M	-10.74M	-4.41M	-6.05M	-10.90M	-6.35M	-8.08M	-11.40M
Income towards Parent Company (Quarter)	-6.97M	-8.35M	-4.96M	-6.27M	-13.00M	-8.49M	-9.48M	-21.47M	45.88M	-29.05M	-187.74M	-13.45M	-12.80M	-10.74M	-4.41M	-6.05M	-10.90M	-6.35M	-8.08M	-11.40M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-6.97M	-8.35M	-4.96M	-6.27M	-13.00M	-8.49M	-9.48M	-21.47M	45.88M	-29.05M	-187.74M	-13.45M	-12.80M	-10.74M	-4.41M	-6.05M	-10.90M	-6.35M	-8.08M	-11.40M
Additional items
EPS (Basic) (Quarter)	-0.18	-0.21	-0.13	-0.16	-0.33	-0.21	-0.24	-0.54	1.15	-0.72	-4.67	-0.33	-0.31	-0.26	-0.11	-0.15	-0.26	-0.15	-0.19	-0.27
EPS (Diluted) (Quarter)	-0.18	-0.21	-0.13	-0.16	-0.33	-0.21	-0.24	-0.54	1.15	-0.72	-4.67	-0.33	-0.31	-0.26	-0.11	-0.15	-0.26	-0.15	-0.19	-0.27
Shares Outstanding (Quarter)	38.73M	39.05M	39.09M	39.01M	39.30M	39.49M	39.51M	39.48M	39.84M	40.22M	40.23M	40.18M	40.65M	40.92M	40.85M	40.85M	41.17M	41.54M	41.60M	41.53M
Shares Outstanding (Diluted) (Quarter)	38.73M	39.05M	39.09M	39.01M	39.30M	39.49M	39.51M	39.48M	39.97M	40.22M	40.23M	40.18M	40.65M	40.92M	40.85M	40.85M	41.17M	41.54M	41.60M	41.53M
EBITDA (Quarter)	-8.10M	-8.68M	-5.29M	-6.40M	-13.30M	-8.12M	-8.93M	-20.84M	35.03M	-13.12M	-199.90M	-14.45M	-13.10M	-11.09M	-9.97M	-5.79M	-10.66M	-6.12M	-12.95M	-10.20M
Interest Expenses (Quarter)	16.63M	16.70M	16.62M	3.80M	16.41M	16.31M	16.04M	2.40M	10.75M	10.82M	10.10M	-1.55M	9.95M	9.94M	9.98M	2.82M	10.26M	10.37M	10.53M	0.41M
Tax Rate (Quarter)	19.01%	5.78%	13.88%	6.77%	6.16%	6.24%	1.85%	1.82%	-31.62%	-130.21%	6.01%	4.89%	-1.05%	1.01%	0.05%	0.98%	-0.60%	0.08%	-0.15%	-3.35%

Research Tools

Developers

Angiodynamics Income Statement (2010-2026) | ANGO

Research Tools

Developers

Angiodynamics Income Statement (2010-2026) | ANGO

Create an account

Sign In

Reset Password